SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-21-000247
Filing Date
2021-02-16
Accepted
2021-02-16 16:06:54
Documents
2
Group Members
ABINGWORTH BIOVENTURES VI, LP

Document Format Files

Seq Description Document Type Size
1 VAXCYTE, INC. 13G vaxcyte_13gdec302020.htm SC 13G 75200
2 JOINT FILING AGREEMENT vaxcyte_13gdec302020exa.htm EX-1 7740
  Complete submission text file 0000905718-21-000247.txt   84491
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13G

Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Subject) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91543 | Film No.: 21638165
SIC: 2836 Biological Products, (No Diagnostic Substances)